Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
Netflix buys up Warner Bros - What does it mean for streaming and markets?
US Open: US indices gain after PCE data 🗽Semiconductor stocks surge
DE40: Adequate data, Mild growth
Chart of the day: CHN.cash (05.12.2025)